Vimarsana
Biggest News Aggregation in the World

Page 25 - Life Sciences Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Life Sciences Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Life Sciences Ltd Today - Breaking & Trending Today

Why the BARD1 (ASX:BD1) share price is surging 10% higher - Vimarsana News

Why the BARD1 (ASX:BD1) share price is surging 10% higher

Why the BARD1 (ASX:BD1) share price is surging 10% higher This healthcare share is on fire today… James Mickleboro has been a Motley Fool contributor since late 2015. After studying economics at university back home in the United Kingdom, James came to live in Australia and managed to land a job at an Australian fund manager. This was the start of a love affair with Australian equities and he hasn't looked back since. James is part of the CFA Institute's Chartered Financial Analyst program and hopes it teaches him how to become an astute investor which allows him to help others with their o...

Healthcare shares rise - Vimarsana News

Healthcare shares rise

Read more about Healthcare shares rise on Business Standard. Healthcare stocks were trading in the positive zone, with the S&P BSE Healthcare index rising 263.67 points or 1.06% at 25160.96 at 09:50 IST.

Healthcare stocks edge higher - Vimarsana News

Healthcare stocks edge higher

Read more about Healthcare stocks edge higher on Business Standard. Healthcare stocks were trading in green, with the S&P BSE Healthcare index increasing 188.39 points or 0.75% at 25244.23 at 09:49 IST.

Spinal Muscular Atrophy Medicine Market – Major Technology Giants in Buzz Again | Astellas Pharma Inc., AveXis Inc., Bioblast Pharma Ltd. – KSU - Vimarsana News

Spinal Muscular Atrophy Medicine Market – Major Technology Giants in Buzz Again | Astellas Pharma Inc., AveXis Inc., Bioblast Pharma Ltd. – KSU

  Latest research study from JCMR with title Global Spinal Muscular Atrophy Medicine Market by Manufacturers, Regions, Type and Application, Fore

Why the BARD1 (ASX:BD1) share price plummeted 9% today - Vimarsana News

Why the BARD1 (ASX:BD1) share price plummeted 9% today

Why the BARD1 (ASX:BD1) share price plummeted 9% today Why the BARD1 (ASX:BD1) share price plummeted 9% today The BARD1 Life Sciences Ltd share price has sunk 9% despite announcing a positive update. We take a closer look at what the company released. Aaron Teboneras has been a Motley Fool contributor since early August 2020. After graduating from RMIT University with a Business degree, Aaron spent most of his years either travelling or working in various industries. Aaron’s most notable appointments include National Australia Bank, and Computershare where he discovered his passion for the ...